AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
47.94
+2.51 (5.52%)
At close: Oct 21, 2026, 4:00 PM EDT
47.67
-0.27 (-0.56%)
After-hours: Oct 21, 2026, 7:40 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.43 billion as of October 21, 2026. It is the 8,555th most valuable company in the world and the 2,033rd biggest in the United States. Its market cap has increased by 45.10% in one year.
Market Cap
1.43B
Enterprise Value
1.54B
1-Year Change
45.10%
Global Rank
Country Rank
#2,033 United States
Category
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.43B, an increase of 364.26%. That is a compound annual growth rate of 17.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 1.43B | 6.77% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.52B |
| First Tracks Biotherapeutics | 1.52B |
| Ascentage Pharma Group International | 1.49B |
| Korsana Biosciences | 1.48B |
| Inhibrx Biosciences | 1.46B |
| ORIC Pharmaceuticals | 1.44B |
| Ocular Therapeutix | 1.42B |
| Tyra Biosciences | 1.41B |